详情页 - 广东省中医院知识库

资源类型：

文章类型：

作者：

Runfeng Li[1] * ; Yunlong Hou[2] ; Jicheng Huang[3] ; Weiqi Pan[1] ; Qinhai Ma[1] ; Yongxia Shi[3] ; Chufang Li[1] ; Jin Zhao[1] ; Zhenhua Jia[2] ; Haiming Jiang[1] ; Kui Zheng[3] ; Shuxiang Huang[3] ; Jun Dai[3] ; Xiaobo Li[3] ; Xiaotao Hou[4] ; Lin Wang[4] ; Nanshan Zhong[1] ; Zifeng Yang[5] ;

机构： [1]State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China. [2]Hebei University of Chinese Medicine, College of Integrated Chinese and Western Medicine, China. [3]Technology Centre, Guangzhou Customs, China. [4]KingMed Virology Diagnostic & Translational Center, China. [5]State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China; State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Taipa, Macau, China; KingMed Virology Diagnostic & Translational Center, China. Electronic address: jeffyah@163.com.

出处：

DOI：

ISSN：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2020]版中科院分区表Review为是的期刊

：

大类 | 2 区医学

小类 | 2 区药学

最新[2025]版：

大类 | 2 区

医学

小类 | 1 区药学

第一作者：

第一作者机构： [1]State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China.

推荐引用方式(GB/T 7714)：

APA：

MLA：

Corrigendum to: Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) [Pharmacol. Res. 156 (2020) 104761].

文献详情